News
InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) ...
Carthera has received an orphan medical device status endorsement for its SonoCloud ultrasound system for treating brain ...
It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...
Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...
Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...
Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...
Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results